Caspase-2 kills cells with extra centrosomes.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
Nov 2024
Historique:
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: ppublish

Résumé

Centrosomes are membrane-less organelles that orchestrate a wide array of biological functions by acting as microtubule organizing centers. Here, we report that caspase-2-driven apoptosis is elicited in blood cells failing cytokinesis and that extra centrosomes are necessary to trigger this cell death. Activation of caspase-2 depends on the PIDDosome multi-protein complex, and priming of PIDD1 at extra centrosomes is necessary for pathway activation. Accordingly, loss of its centrosomal adapter, ANKRD26, allows for cell survival and unrestricted polyploidization in response to cytokinesis failure. Mechanistically, cell death is initiated upstream of mitochondria via caspase-2-mediated processing of the BCL2 family protein BID, driving BAX/BAK-dependent mitochondrial outer membrane permeabilization (MOMP). Remarkably, BID-deficient cells enforce apoptosis by engaging p53-dependent proapoptotic transcriptional responses initiated by caspase-2. Consistently, BID and MDM2 act as shared caspase-2 substrates, with BID being kinetically favored. Our findings document that the centrosome limits its own unscheduled duplication by the induction of PIDDosome-driven mitochondrial apoptosis to avoid potentially pathogenic polyploidization events.

Identifiants

pubmed: 39475598
doi: 10.1126/sciadv.ado6607
doi:

Substances chimiques

Caspase 2 EC 3.4.22.-
BH3 Interacting Domain Death Agonist Protein 0
Death Domain Receptor Signaling Adaptor Proteins 0
PIDD1 protein, human 0
CASP2 protein, human EC 3.4.22.-
Proto-Oncogene Proteins c-mdm2 EC 2.3.2.27
Tumor Suppressor Protein p53 0
BID protein, human 0
MDM2 protein, human EC 2.3.2.27
Cysteine Endopeptidases EC 3.4.22.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eado6607

Auteurs

Dario Rizzotto (D)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.

Vincenza Vigorito (V)

Armenise-Harvard Laboratory of Cell Division, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, Trento, Italy.

Patricia Rieder (P)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.

Filip Gallob (F)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.

Gian Mario Moretta (GM)

Armenise-Harvard Laboratory of Cell Division, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, Trento, Italy.

Claudia Soratroi (C)

Institute for Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Joel S Riley (JS)

Institute for Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Florian Bellutti (F)

Armenise-Harvard Laboratory of Cell Division, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, Trento, Italy.

Stefano Li Veli (SL)

Armenise-Harvard Laboratory of Cell Division, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, Trento, Italy.

Alessia Mattivi (A)

Armenise-Harvard Laboratory of Cell Division, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, Trento, Italy.

Michael Lohmüller (M)

Institute for Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Sebastian Herzog (S)

Institute for Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Beat C Bornhauser (BC)

Department of Oncology and Children's Research Centre, University Children's Hospital Zürich, 8032 Zürich, Switzerland.

Etienne D Jacotot (ED)

Inserm U1268, Medicinal Chemistry and Translational Research, Paris F-75006, France.
Faculté de Pharmacie, UMR 8038 CiTCoM, Université Paris Cité, Paris F-75006, France.

Andreas Villunger (A)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
Institute for Developmental Immunology, Biocenter, Medical University Innsbruck, 6020 Innsbruck, Austria.

Luca L Fava (LL)

Armenise-Harvard Laboratory of Cell Division, Department of Cellular, Computational and Integrative Biology-CIBIO, University of Trento, Trento, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH